Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
Main Study Objectives:
The study is conducted to
- evaluate the minimal allopurinol and azathioprine doses that, in combination, produce
therapeutic 6-TGN levels
- evaluate the safety and tolerability of the different allopurinol/azathioprine dose
levels
- assess if concomitant allopurinol affects TPMT activity
- assess the clinical efficacy of concomitant allopurinol-azathioprine therapy in the
included patients